Brief: MaxCyte Q3 Gross Profit USD 5.2 Million
12/11/2025 21:05
Nov 12 (Reuters) - MaxCyte Q3 net income USD -12.4 million. Q3 operating expenses USD 19.4 million Q3 adjusted EBITDA USD -10 million vs. IBES estimate USD -10.4 million
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026